When was EntangleBio founded?

EntangleBio was founded in 2026 and raised its 1st funding round within a year of its incorporation.

Where is EntangleBio located?

EntangleBio is headquartered in Dover, United States.

Is EntangleBio a funded company?

EntangleBio is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Apr 09, 2026.

When was the latest funding round of EntangleBio?

EntangleBio's latest funding was a $***** Seed round on Apr 09, 2026, with participation from 1 investor. Its primary sector is Genomics. In United States, the Genomics sector has seen $1.84B in funding in 2026 to date.

Where does EntangleBio rank among its competitors?

EntangleBio ranks 25th amongst 27 active competitors, of which 8 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was astromech, which secured $20M in Aug, 2026.

Who are the top competitors of EntangleBio?

EntangleBio's top competitors include Enhanced Genomics, VedaBio and astromech. Among them, astromech secured the most recent funding round in August, 2026.

EntangleBio - 2026 Company Profile, Funding & Competitors

Company Details

Developer of computational platforms identifying genetic interactions for rare diseases. This technology integrates network medicine with quantum computing to analyze biological data. The system identifies complex genetic combinations to assist in the diagnosis and treatment of conditions that remain undiagnosed through standard analytical methods.

Key Metrics

Founded Year

2026

Location

Dover, United States

Stage

Seed

Total Funding

$250K in 1 round

Latest Funding Round

Seed, Apr 09, 2026, $*****

Investors

K5 Global

Ranked

25^th among 27 active competitors

Similar Companies

Enhanced Genomics & 30 more

View EntangleBio's full profile

EntangleBio has raised a total funding of $250K over 1 round. Its latest funding round was a Seed round on Apr 09, 2026 for $*****. 1 investor participated in its latest round. EntangleBio has 1 institutional investor.

Here is the list of recent funding rounds of EntangleBio:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 09, 2026	7824301	Seed	7242953	4965385	9612298	6855850

Access funding benchmarks and valuations. Sign up today!

View details of EntangleBio's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of EntangleBio include Enhanced Genomics, VedaBio and astromech. Here is the list of Top 10 competitors of EntangleBio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Enhanced Genomics 2020, Cambridge (United Kingdom), Series A	Digital platform focused on decoding the causal biology behind genetic variations to accelerate drug discovery	$19M	Parkwalk, BGF & 1 others	55/100
2nd	VedaBio 2021, San Diego (United States), Series A	Provider of molecular detection and editing platform using CRISPR Cascade technology	$40.1M	OMX Ventures, Tao Capital Partners & 2 others	54/100
3rd	astromech Series B	Developer of AI systems for biological data analysis and design	$60M	PEAK6, CAZ Investments & 2 others	44/100
4th	Aligned Bio 2019, Lund (Sweden), Seed	Provider of nanowire-based sensors	$909K	Almi Invest, EIC Fund & 5 others	42/100
5th	Singular Bio 2012, San Francisco (United States), Acquired	Tools for single molecule detection	$6.58M	The Vertical Group, Prefix Capital & 1 others	39/100
6th	Nooma Bio 2020, Santa Cruz (United States), Seed	Developer of dual-nanopore technology for genome-wide structural and epigenetic variations	-	Khosla Ventures, DEFTA Partners	37/100
7th	YouScript 2000, Seattle (United States), Acquired	Developer of clinical decision support analytics software	-	Springboard Enterprises, Cascadia Venture Forum	33/100
8th	Dimension Genomics 2021, San Diego (United States), Series A	Provider of solutions for genome analysis and interpretation	$4M	-	32/100
9th	Acuity Spatial Genomics 2020, Watertown (United States), Acquired	Developer of 3D genomics platform for multi-omic analyses	-	-	30/100
10th	HAWK Biosystems 2015, Derio (Spain), Seed	Developer of clinical assays for quantifying novel biomarkers	-	EIC Fund, Europa	30/100
25th	EntangleBio 2026, Dover (United States), Seed	Developer of computational platforms identifying genetic interactions for rare diseases	$250K	K5 Global	19/100